XTL BIOPHARMACEUTICALS LTD Quarterly Liabilities in USD for Q2 2024

Taxonomy & unit
ifrs-full: USD
Summary
Xtl Biopharmaceuticals Ltd quarterly Liabilities history and growth rate for Q2 2024.
  • Xtl Biopharmaceuticals Ltd Liabilities for the quarter ending August 14, 2024 was $5.84M.
Liabilities, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $5.84M Aug 14, 2024 20-F 2025-04-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.